FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

INTERCELL AG 		2. Issuer Name and Ticker or Trading Symbol

IOMAI CORP [ IOMI ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

CAMPUS VIENNA BIOCENTER 6 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/1/2008
(Street)

VIENNA, C4 1030
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   8/1/2008     P    309004   A   (1) 10608768   (2) D    
Common Stock                  2776211   (3) I   See note   (3)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   $5.25   8/1/2008   (2)   (2) X        94500    3/2/2007   3/2/2012   Common Stock   94500   $0.00   550535   I   See note   (4)

Explanation of Responses:
( 1)  Acquired on August 1, 2008, pursuant to the closing of a share exchange agreement, dated as of May 12, 2008 by and between Intercell AG ("Intercell") and certain Iomai Corporation stockholders (the "Exchange Agreement").
( 2)  Includes, in addition to the shares of Common Stock being reported as an acquisition of beneficial ownership by Intercell, the following shares of Common Stock also acquired by Intercell pursuant to the Exchange Agreement (i) 10,205,264 shares previously owned by certain stockholders of Iomai Corporation ("Iomai") that Intercell, on a Form 3/A dated May 12, 2008 (the "Form 3/A"), reported as beneficially owned indirectly based on the terms of a voting agreement, dated as of May 12, 2008, by and between Intercell and certain Iomai stockholders (the "Voting Agreement") and (ii) 94,500 shares acquired by Iomai stockholders pursuant to the exercise of Warrants that Intercell previously reported as beneficially owned indirectly on Table II of the Form 3/A based on the terms of the Voting Agreement.
( 3)  Consists of 2,776,211 shares that Intercell may be deemed to beneficially own indirectly based on the terms of the Voting Agreement.
( 4)  Consists of Warrants to purchase shares of Common Stock owned by Iomai stockholders that Intercell may be deemed to beneficially own indirectly based on the terms of the Voting Agreement.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
INTERCELL AG
CAMPUS VIENNA BIOCENTER 6
VIENNA, C4 1030
X


Signatures
/s/ Gerd Zettlmeissl 8/1/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Iomai Corp (MM) (NASDAQ:IOMI)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Iomai Corp (MM) Charts.
Iomai Corp (MM) (NASDAQ:IOMI)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Iomai Corp (MM) Charts.